The Integrin Binding Peptide, ATN-161, as a Novel Therapy for SARS-CoV-2 Infection Article

Beddingfield, Brandon J, Iwanaga, Naoki, Chapagain, Prem P et al. (2021). The Integrin Binding Peptide, ATN-161, as a Novel Therapy for SARS-CoV-2 Infection . 6(1), 1-8. 10.1016/j.jacbts.2020.10.003

Open Access ESI Most Cited Paper

cited authors

  • Beddingfield, Brandon J; Iwanaga, Naoki; Chapagain, Prem P; Zheng, Wenshu; Roy, Chad J; Hu, Tony Y; Kolls, Jay K; Bix, Gregory J

sustainable development goals

authors

publication date

  • January 25, 2021

webpage

keywords

  • AC-PHSCN-NH2
  • ACE2
  • ATN-161
  • CELLS
  • COVID-19
  • Cardiac & Cardiovascular Systems
  • Cardiovascular System & Cardiology
  • DOCKING
  • Life Sciences & Biomedicine
  • SARS-CoV-2
  • SEQUENCE
  • Science & Technology
  • UPDATE
  • alpha5beta1 integrin
  • host-cell entry
  • receptor binding domain
  • therapeutic
  • viral spike protein

Digital Object Identifier (DOI)

publisher

  • ELSEVIER SCIENCE INC

start page

  • 1

end page

  • 8

volume

  • 6

issue

  • 1